Leukocyte Adhesion as an Indicator of Oxygenator Thrombosis During Extracorporeal Membrane Oxygenation Therapy?

Area of Science:

• Cardiovascular Research
• Biomedical Engineering
• Hematology

Background:

• Thrombosis is a primary technical complication in extracorporeal membrane oxygenation (ECMO).
• Leukocyte accumulation on membrane oxygenator (MO) gas exchange membranes may initiate thrombosis and impact patient outcomes.
• Understanding cellular deposits in MOs is crucial for improving ECMO safety and efficacy.

Purpose of the Study:

• To investigate the characteristics of cellular deposits, specifically pseudomembranes (PM), within MOs used in ECMO.
• To correlate the presence and extent of PM with patient demographics and clinical data.
• To assess the impact of PM on MO performance, thrombosis, and patient outcomes during ECMO.

Main Methods:

• Analysis of 41 routinely removed MOs from adult ECMO patients.
• Cellular deposit analysis using nuclear staining (4',6-diamidino-2-phenylindole) and cell-specific markers (CD45, von Willebrand factor).
• Correlation of cellular colonization extent with patient data, including age, leukocyte count, coagulation parameters, and ECMO support duration.

Main Results:

• Six MOs exhibited pseudomembranes (PM), predominantly in younger patients (median age 36 years) with higher pre-ECMO leukocyte counts.
• PM presence did not significantly affect MO pressure drop or coagulation parameters (d-dimers, fibrinogen, platelets).
• Only one acute MO thrombosis occurred in a PM-free MO; patients with PMs had higher successful weaning and hospital discharge rates (p=0.027).

Conclusions:

• Reduced pseudomembrane (PM) formation in elderly ECMO patients may be associated with a lower risk of membrane oxygenator (MO) thrombosis.
• The presence of PMs in MOs did not negatively impact younger patients and was linked to better clinical outcomes.
• Further research into PM formation mechanisms could lead to strategies for mitigating ECMO-related complications.